CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 10-K Report Annual Report
- 8-K Event Material agreement · Results of operations · Unregistered share sale · Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award Chief Medical Officer acquired 968 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 467 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 937 shares (grant or award)
- 4 Grant or award President and CEO acquired 1,055 shares (grant or award)
- 4 Shares withheld for taxes President and CEO gave up 2,353 shares (to pay taxes)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Shares withheld for taxes President and CEO gave up 3,025 shares (to pay taxes)
- S-3 Offering Registration Statement
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 20 of 74 · 1,467 filings